Glycerin
NDC 68016-161, Glycerin, suppository, from Chain Drug Consortium LLC.
- Product NDC
- 68016-161
- Status
- Listed
- Labeler
- Chain Drug Consortium LLC
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68016-161 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCERIN1 g/1
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68016-161-00 | 68016016100 | 25 SUPPOSITORY in 1 JAR (68016-161-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68016-161 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68016-161 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68016-161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.